Held in the Aula Magna of Palazzo del Bo, the University of Padua hosts the "Science and Innovation for Effective and Sustainable Healthcare" event on Monday, 20 November. Welcoming representatives from several Italian institutions, members of the National Center for Gene Therapy and Drugs based on RNA Technology, and distinguished scholars, the event also brings the participation of the Italian Minister of University and Research, Anna Maria Bernini.

Focused on the development of gene therapy and drug treatments through RNA technology, the National Center organizes the event as an opportunity to discuss and share an in-depth analysis of the issues related to its activities as it responds to some of the most urgent and complex medical challenges of today.

With welcoming remarks from the University of Padua Rector Daniela Mapelli and Mayor of Padua Sergio Giordani, the event includes talks by Prof Rosario Rizzuto, Prof Giorgio Palù, Dr. Franco Locatelli and Prof Angela Zampella. 

As a University of Padua professor, Rosario Rizzuto is also the President of the National Center for Gene Therapy and Drugs based on RNA Technology. Giorgio Palù is the President of the Italian Medicines Agency and Emeritus professor at the University of Padua. A Director at the Ospedale Pediatrico Bambino Gesù (IRCCS) Dr. Franco Locatelli is also the President of Italy’s Higher Health Council (CSS) and Vice-Chairman of the National Center for Gene Therapy and Drugs based on RNA Technology. Prof Angela Zampella is the Director of the Department of Pharmacy at the University of Naples Federico II and the Supervisory Board President of the National Center for Gene Therapy and Drugs based on RNA Technology.

Followed with a round table moderated by Luigi Ripamonti, journalist and editor-in-chief of Corriere Salute and the Health section of the Corriere della Sera website.

The full programme and link to the livestreaming event is available at  https://www.rna-genetherapy.eu.

The National Center brings together 46 public and private research Italian institutions and companies to assemble a network of experts across different disciplines such as molecular biology, genetics, biotechnology, and clinical medicine.

Composed of 10 Spokes, the National Center acts as the Hub focused on innovative energies within different but related projects. By creating cutting-edge infrastructures and laboratories, the Center encourages entrepreneurial initiatives with high technological content to enhance the results of scientific and clinical research.

Focused on making healthcare effective and sustainable, the National Center aims to translate research results into concrete clinical application through the development of personalized medicines.  By working together, the first object of the National Center is improving the lives of those suffering from genetic diseases.